Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) fell by -7.80% in Thursday’s trading session from $7.37 to $6.80. The price has fallen in 7 of the last 10 days and is down by -6.15% over the same course of time. Volume has increased in Thursday’s trading session by 0.74 million shares, but on a weak note. This is may be an early warning and the risk will be increased slightly for the next couple of days. In total, 1.57 M shares exchanged hands for about $10.70 million.
Inside KERX’s Recent Trend
Keryx Biopharmaceuticals, Inc. (KERX) lies in the middle of a very wide and weak rising trend in the short term and issued considerable signs about additional rally. Short-term traders are predicted to see a rally of 3.19% over the course of a quarter and, with 90% chance the price will be floating in the range of $6.28 and $8.71 in this timeframe.
Keryx Biopharmaceuticals, Inc. Technical Signals
KERX has witnessed its long term and short term MA triggering a sell signal. Upon corrections, the price will meet resistance from the averages between $7.41 and $7.00. A buy signal will be generated if it crosses above any of these levels. Its pivot point high generated sell signal on Wednesday September 06, 2017, which calls for additional declines until the stock forms a new pivot point low, as this could be a buying opportunity. Volume up and price depreciating is getting our attention as this movement is seen as bearish sign.
Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) Support And Resistance Levels
Keryx Biopharmaceuticals, Inc. (KERX) recorded volume accumulation so there will probably be a surplus of buyers at $6.75. In case of gains, the next resistance from accumulated volume will be at $7.17, $7.80 and $7.86.
Keryx Biopharmaceuticals, Inc. (KERX) Risk Assessment
A volatility based measure Bollinger Bands suggests this stock poses high risk. In the most recent session, the stock price hovered around $0.65 between high and low, or 9.63%. The average volatility for the past week stood at 4.86%.